Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6314-6320

  Lortholary, Olivier ^a   Improvisi, Luce ^a   Rayhane, Naima ^a   Gray, Francoise ^b   Fitting, Catherine ^a   Cavaillon, Jean Marc ^a   Dromer, Francoise ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGEMIA; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MICE; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032699913     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. J. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Amiot, F., C. Fitting, K. J. Tracey, J. M. Cavaillon, and F. Dautry. 1997. Lipopolysaccharide-induced cytokine cascade and lethality in LTα/TNFα-deficient mice. Mol. Med. 3:864-875.
3. Barluzzi, R., R. Mazzolla, A. Brozzetti, M. Puliti, G. Mariucci, P. Mosci, F. Bistoni, and E. Blasi. 1997. A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis. J. Neuroimmunol. 79:37-48.
4. Bennett, J. E., and H. F. Hasenclever. 1965. Cryptococcus neoformans polysaccharide: studies of serologic properties and role in infection. J. Immunol. 94:916-920.
5. Blasi, E., R. Barluzzi, R. Mazzolla, L. Pitzurra, M. Puliti, S. Saleppico, and F. Bistoni. 1995. Biomolecular events involved in anticryptococcal resistance in the brain. Infect. Immun. 63:1218-1222.
6. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. American Society for Microbiology, Washington, D.C.
7. Chaka, W., A. F. M. Verheul, and A. I. M. Hoepelman. 1997. Influence of different conditions on kinetics of tumor necrosis factor alpha release by peripheral blood mononuclear cells after stimulation with Cryptococcus neoformans: a possible explanation for different results. Clin. Diagn. Lab. Med. 4:792-794.
8. Chaka, W., A. F. M. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhoef, H. Snippe, and I. M. Hopelman. 1997. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect. Immun. 65:272-278.
9. Chensue, S. W., P. D. Terebuh, D. G. Remick, W. E. Scales, and S. L. Kunkel. 1991. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138:395-402.
10. Cross, C. E., and G. J. Bancroft. 1995. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 63:2604-2611.
11. Decken, K., G. Köhler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994-5000.
12. Delfino, D., L. Cianci, E. Lupis, A. Celeste, M. L. Petrelli, F. Curro, V. Cusumano, and G. Teti. 1997. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect. Immun. 65: 2454-2456.
13. Delfino, D., L. Cianci, M. Migliardo, G. Mancuso, V. Cusumano, C. Corradini, and G. Teti. 1996. Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect. Immun. 64:5199-5204.
14. Diamond, R. D. 1995. Cryptococcus neoformans, p. 2331-2340. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
15. Dromer, F., and J. Charreire. 1991. Improved amphotericin B (AMB) activity by a monoclonal anti-Cryptococcus neoformans antibody. J. Infect. Dis. 163:1114-1120.
16. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218-224.
17. Havell, E. A., and P. B. Sehgal. 1991. Tumor necrosis factor-independent IL-6 production during murine listeriosis. J. Immunol. 146:756-761.
18. Hoag, K. A., M. F. Lipscomb, A. A. Izzo, and N. E. Street. 1997. IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17: 733-739.
19. Huffnagle, G. B. 1996. Role of cytokines in T-cell immunity to a pulmonary Cryptococcus neoformans infection. Biol. Signals 5:215-222.
20. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507-3516.
21. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536.
22. Joly, V., L. Saint-Julien, C. Carbon, and P. Yeni. 1994. In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis. J. Infect. Dis. 178:1331-1334.
23. Kawakami, K., X. Qifeng, M. Tohyama, M. H. Qureshi, and A. Saito. 1996. Contribution of tumour necrosis factor-alpha (TNF-α) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 106:468-474.
24. Kawakami, K., M. Tohyama, X. Qifeng, and A. Saito. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1307-1312.
25. Kawakami, K., M. Tohyama, Q. Sie, and A. Saito. 1996. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208-214.
26. Lee, S. C., D. W. Dickson, C. F. Brosnan, and A. Casadevall. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:365-369.
27. Lee, S. C., D. W. Dickson, and A. Casadevall. 1996. Pathology of cryptococcal meningoencephalitis. Analysis of 27 patients with pathogenetic implications. Hum. Pathol. 27:839-847.
28. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62:1975-1981.
29. Levitz, S. M., A. Tabuni, S. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945-951.
30. Li, R. K., and T. G. Mitchell. 1997. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum. J. Med. Vet. Mycol. 35:327-334.
31. 30a. Lortholary, O., L. Improvisi, N. Rayhane, M. Nichols, C. Fitting, B. DuPont, J. M. Cavaillon, and F. Dromer. 1998. Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, abstr. J-055. American Society for Microbiology, Washington, D.C.
32. Lortholary, O., L. Improvisi, M. Nicolas, F. Provost, B. Dupont, and F. Dromer. 1999. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med. Mycol. 37:169-174.
33. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
34. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
35. Munoz, C., B. Misset, C. Fitting, J. P. Blériot, J. Carlet, and J. M. Cavaillon. 1991. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21:2177-2184.
36. Murphy, J. W. 1989. Immunoregulation in cryptococcosis, p. 319-345. In E. Kurstak (ed.), Immunology of fungal diseases. Marcel Dekker, Inc., New York, N.Y.
37. Rayhane, N., O. Lortholary, C. Fitting, J. Callebert, M. Huerre, F. Dromer, and J. M. Cavaillon. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-α deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, gamma-interferon and interleukin 12. J. Infect. Dis., in press.
38. Retini, C., A. Vecchiarelli, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 64:2897-2903.
39. Vecchiarelli, A., C. Retini, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:2846-2849.
40. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, C. Tascini, T. Beccari, and T. R. Kozel. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect. Immun. 63:2919-2923.
41. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:811-816.
42. Yuan, R., A. Casadevall, J. Oh, and M. D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94:2483-2488.